Lyon (France), March 2, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its senior management will present and meet with investors at upcoming investor conferences in the United States and Europe.
Um die vollständige Version abzurufen, klicken Sie bitte auf das untenstehende PDF.